Bliss GVS Pharma506197Promoter pledge update
Bliss GVS Pharma Ltd shareholder buys 47.95% stake
47.95%W.r.t. total share/voting capital
- Transaction Type
- Pledge of equity shares of the Target Company
- Counterparty / Transacting Entity
- Catalyst Trusteeship Limited acting as Debenture Trustee on behalf of Debenture holders (Non-promoters)
- Transaction
- Shares bought
- Stake bought
- 47.95%
- Shares
- 5,09,84,595
Bliss GVS Pharma Ltd shareholder buys 47.95% stake.
Also from Bliss GVS Pharma
Board approves Senior Executive ESOP 2026 and Employee ESOP 2026; options up to 26,50,000 and 47,00,000 shares
1 Oct 2026
Bliss GVS Pharma Ltd promoter buys 47.95% stake, holding rises to 50.07%^#%
1 Oct 2026
Bliss GVS shares fell 3% after promoter entity Anupam Rasayan bought the required 2% stake to cross the 50% ownership mark
29 Sep 2026
More numbers
- Equity shares pledged (encumbrance)5,09,84,595
- % w.r.t. total share/voting capital47.95%
- % w.r.t. total diluted share/voting capital46.77%
- Equity share capital of TC before acquisitionINR 10,63,30,472
- Total diluted share/voting capital of TC after acquisitionINR 10,90,11,222
- Shares transacted5,09,84,595
- Percentage of share capital47.95%
Source: BSE · 6 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.